B group | NB group | p | |
---|---|---|---|
n | 97 | 45 | |
Age (median) (yrs) | 74.8 ± 10.4 (77) | 71.4 ± 8.3 (72) | 0.0054* |
Gender male n (%) | 56 (58) | 21 (47) | 0.2186 |
Body mass index (kg/m2) | 22.1 ± 3.7 (22.2) | 20.8 ± 3.6 (20.7) | 0.0796 |
Open-heart surgery n (%) | 21 (22) | 32 (71) | < 0.0001 |
Mitral prosthesis n (%) | 10 (10) | 22 (49) | < 0.0001 |
Postoperative period (median) (yrs) | 19.7 ± 11.0 (19) | 21.1 ± 9.3 (21) | 0.6290* |
Hypertension n (%) | 56 (58) | 12 (27) | 0.0005 |
Diabetes mellitus n (%) | 25 (26) | 12 (27) | 0.9103 |
Dyslipidemia n (%) | 22 (23) | 4 (8) | 0.0617 |
AngiotensinII receptor blockers/angiotensin- converting enzyme inhibitors n (%) | 74 (76) | 24 (53) | 0.0067 |
Digitalis n (%) | 21 (23) | 23 (55) | 0.0004 |
Calcium channel blockers n (%) | 32 (36) | 12 (29) | 0.4245 |
β blockers n (%) | 35 (39) | 9 (21) | 0.0426 |
Warfarin n (%) | 37 (42) | 29 (69) | 0.0030 |
Diuretics n (%) | 55 (61) | 37 (88) | 0.0020 |
Spironolactone n (%) | 34 (38) | 26 (62) | 0.0094 |
NYHA II n | 77 | 36 | 0.9321 |
III n | 20 | 9 | |
Dyspnea n (%) | 84 (88) | 40 (91) | 0.7752 |
General malaise n (%) | 9 (9) | 14 (31) | 0.0018 |
Extra sound n (%) | 8 (9) | 1 (2) | 0.2711 |
LV distension n (%) | 33 (41) | 22 (54) | 0.1948 |
Hepatomegaly n (%) | 32 (33) | 24 (53) | 0.0244 |
Peripheral edema n (%) | 50 (52) | 21 (47) | 0.5486 |
Systolic blood pressure (median) (mmHg) | 136.2 ± 23.6 (134.0) | 134.4 ± 17.2 (132.0) | 0.6778* |
Diastolic blood pressure (median) (mmHg) | 74.2 ± 14.8 (72.0) | 72.3 ± 13.2 (70.0) | 0.2300* |
Heart rate (median) (bpm) | 81.3 ± 66.5 (72.0) | 74.4 ± 17.0 (72.0) | 0.6566* |
ANP (median) (pg/ml) | 122.5 ± 185.4 (82.0) | 29.0 ± 59.6 (15.0) | < 0.0001* |
BNP (median) (pg/ml) | 380.7 ± 259.1 (318.0) | 59.7 ± 27.1 (60.8) | |
Plasma aldosterone (median) (ng/dl) | 6.9 ± 5.7 (5.0) | 17.6 ± 24.1 (10.8) | < 0.0001* |
Plasma norepinephrine (median) (ng/ml) | 0.45 ± 0.29 (0.40) | 0.38 ± 0.20 (0.36) | 0.4405* |
Serum creatinine (median) (mg/dl) | 1.07 ± 0.46 (0.94) | 0.96 ± 0.48 (0.90) | 0.2460* |
Hemoglobin (median) (g/dl) | 11.9 ± 2.1 (12.1) | 11.8 ± 2.1 (12.3) | 0.9163* |
Serum sodium (median) (mEq/L) | 140.2 ± 3.9 (141.0) | 140.1 ± 8.6 (140.0) | 0.1607* |
Chest radiograph: | |||
Cardiothoracic ratio (%) | 61.2 ± 10.0 | 66.0 ± 14.3 | 0.0484* |
Congestion n (%) | 23 (26) | 3 (12) | 0.1826 |
Effusion n (%) | 44 (50) | 23 (58) | 0.4303 |
ECG: | |||
High voltage n (%) | 10 (14) | 4 (14) | > 0.9999 |
ST change n (%) | 34 (48) | 13 (43) | 0.6750 |
Intraventricular conduction disturbance | |||
n (%) | 18 (21) | 10 (28) | 0.4366 |
Atrial fibrillation n (%) | 47 (57) | 29 (73) | 0.0854 |
Pericardial thickness (median) (mm) | 2.4 ± 1.1 (2.1) | 2.9 ± 1.9 (2.0) | 0.5886* |